Literature DB >> 21784279

Contrast-induced acute kidney injury: short- and long-term implications.

Steven D Weisbord1, Paul M Palevsky.   

Abstract

The intravascular administration of iodine-based contrast media remains a common cause of acute kidney injury and a leading cause of iatrogenic renal disease. Past research has elucidated the principal risk factors for contrast-induced acute kidney injury (CIAKI) and helped to establish the efficacy of various interventions for the prevention of this condition. The importance of preventing CIAKI has been underscored by a growing number of studies showing strong associations of CIAKI with serious adverse short- and long-term outcomes. However, it remains unclear whether these associations are causal. This is important because considerable health care resources are used to prevent CIAKI. If CIAKI is a marker, but not a mediator, of serious adverse downstream outcomes, more judicious and selective use of preventive care may be appropriate. Moreover, with an increasing number of studies reporting the underuse of coronary angiography in patients with acute coronary syndrome and underlying chronic kidney disease, presumably in part because of a fear of CIAKI, a clear understanding of whether this condition directly results in adverse downstream outcomes is essential. Careful inspection of past studies that investigated the association of CIAKI with adverse short- and long-term events sheds light on their strengths and weaknesses and provides insight into how future research may be better able to characterize the short- and long-term implications of this iatrogenic condition. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784279      PMCID: PMC3143363          DOI: 10.1016/j.semnephrol.2011.05.009

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  120 in total

1.  Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.

Authors:  Steven C Faddy
Journal:  Am J Cardiol       Date:  2004-08-01       Impact factor: 2.778

Review 2.  Strategies to reduce the risk of contrast-induced nephropathy.

Authors:  Fulvio Stacul; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Peter A McCullough; James Tumlin
Journal:  Am J Cardiol       Date:  2006-03-20       Impact factor: 2.778

Review 3.  Risk prediction of contrast-induced nephropathy.

Authors:  Peter A McCullough; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Fulvio Stacul; James Tumlin
Journal:  Am J Cardiol       Date:  2006-02-23       Impact factor: 2.778

4.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency.

Authors:  L Gruberg; G S Mintz; R Mehran; G Gangas; A J Lansky; K M Kent; A D Pichard; L F Satler; M B Leon
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

5.  Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.

Authors:  Jin H Han; Abhinav Chandra; Jyotsna Mulgund; Matthew T Roe; Eric D Peterson; Lynda A Szczech; Uptal Patel; E Magnus Ohman; Christopher J Lindsell; W Brian Gibler
Journal:  Am J Med       Date:  2006-03       Impact factor: 4.965

6.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study.

Authors:  Alejandro Recio-Mayoral; Marinela Chaparro; Belén Prado; Rocío Cózar; Irene Méndez; Debasish Banerjee; Juan C Kaski; José Cubero; Jose M Cruz
Journal:  J Am Coll Cardiol       Date:  2007-03-12       Impact factor: 24.094

7.  Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.

Authors:  Lilach Shema; Liora Ore; Ronit Geron; Batya Kristal
Journal:  Isr Med Assoc J       Date:  2009-08       Impact factor: 0.892

Review 8.  Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Authors:  Sankar D Navaneethan; Sonal Singh; Suresh Appasamy; Richard E Wing; Ashwini R Sehgal
Journal:  Am J Kidney Dis       Date:  2008-11-22       Impact factor: 8.860

9.  Contrast-induced nephropathy and long-term adverse events: cause and effect?

Authors:  Richard J Solomon; Roxana Mehran; Madhu K Natarajan; Serge Doucet; Richard E Katholi; Cezar S Staniloae; Samin K Sharma; Marino Labinaz; Joseph L Gelormini; Brendan J Barrett
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-25       Impact factor: 8.237

10.  Provider use of preventive strategies for radiocontrast nephropathy in high-risk patients.

Authors:  Steven D Weisbord; Frank J Bruns; Melissa I Saul; Paul M Palevsky
Journal:  Nephron Clin Pract       Date:  2004
View more
  15 in total

1.  The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice.

Authors:  Andreas Linkermann; Jan-Ole Heller; Agnes Prókai; Joel M Weinberg; Federica De Zen; Nina Himmerkus; Attila J Szabó; Jan H Bräsen; Ulrich Kunzendorf; Stefan Krautwald
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

Review 2.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

3.  Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention.

Authors:  Ying Yuan; Hong Qiu; Xiaoying Hu; Tong Luo; Xiaojin Gao; Xueyan Zhao; Jun Zhang; Yuan Wu; Shubin Qiao; Yuejin Yang; Runlin Gao
Journal:  Clin Cardiol       Date:  2017-05-19       Impact factor: 2.882

4.  Statins in the prevention of contrast-induced nephropathy.

Authors:  Anthony C Chyou; Anay Thodge; Dmitriy N Feldman; Rajesh V Swaminathan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-04

Review 5.  Strategies for Renal Protection in Cardiovascular Interventions.

Authors:  Ziad A Ali; Javier Escaned; Dariusz Dudek; Jai Radhakrishnan; Keyvan Karimi Galougahi
Journal:  Korean Circ J       Date:  2022-07       Impact factor: 3.101

6.  Alprostadil plays a protective role in contrast-induced nephropathy in the elderly.

Authors:  Ya Miao; Yuan Zhong; Hong Yan; Wei Li; Bei-Yun Wang; Jun Jin
Journal:  Int Urol Nephrol       Date:  2013-07-17       Impact factor: 2.370

7.  Clinically useful dilution factors for iodine and gadolinium contrast material: an animal model of pediatric digital subtraction angiography using state-of-the-art flat-panel detectors.

Authors:  John M Racadio; Soumya R Kashinkunti; Rami A Nachabe; Judy M Racadio; Neil D Johnson; Kamlesh U Kukreja; Manish N Patel; Mary Beth Privitera; Jasmine E Hales; Todd A Abruzzo
Journal:  Pediatr Radiol       Date:  2013-06-05

8.  Risk Factors of Contrast-induced Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention.

Authors:  Ying Yuan; Hong Qiu; Xiao-Ying Hu; Tong Luo; Xiao-Jin Gao; Xue-Yan Zhao; Jun Zhang; Yuan Wu; Hong-Bing Yan; Shu-Bin Qiao; Yue-Jin Yang; Run-Lin Gao
Journal:  Chin Med J (Engl)       Date:  2017 5th Jan 2017       Impact factor: 2.628

9.  Relationship between High Level of Estimated Glomerular Filtration Rate and Contrast-Induced Acute Kidney Injury in Patients who Underwent an Emergency Percutaneous Coronary Intervention.

Authors:  Ying Yuan; Hong Qiu; Xiao-Ying Hu; Tong Luo; Xiao-Jin Gao; Xue-Yan Zhao; Jun Zhang; Yuan Wu; Shu-Bin Qiao; Yue-Jin Yang; Run-Lin Gao
Journal:  Chin Med J (Engl)       Date:  2018-09-05       Impact factor: 2.628

10.  Predictive factors for contrast-induced acute kidney injury in high-risk patients given N-acetylcysteine prophylaxis.

Authors:  Wei-Yoon Poh; Marhanis Salihah Omar; Hwee-Pheng Tan
Journal:  Ann Saudi Med       Date:  2018 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.